Market Context — Why This Technology, Why Now

The increasing complexity of preclinical drug development and the global push for higher ethical standards in animal research are driving demand for more precise and humane animal care. Regulatory bodies worldwide are tightening guidelines for animal facility hygiene, making robust pathogen screening essential. This technology aligns perfectly with these trends, offering a solution that not only improves research quality but also supports animal welfare by enabling rapid and accurate health monitoring.

Key Competitive Advantages
01

Reduces detection time by ~66% (1/3 of original time) compared to conventional methods, potentially tripling throughput from sample preparation to PCR detection.

02

Increases detection sensitivity by 5x, enabling highly sensitive and specific detection of trace pinworm DNA using LNA-containing primers and probes, reducing false negatives.

03

Simplifies sample preparation with an alcohol precipitation method, eliminating the need for specialized equipment or skilled technicians, thereby streamlining routine screening.

Market Opportunity
🔬 Pharmaceutical Development & Preclinical Trials
~$1.5B globally (AI est.)
Increasing stringency in animal testing for new drug development and rising international quality standards drive continuous demand for high-precision pathogen screening.
Contract research organizations (CROs) specializing in preclinical studies Large pharmaceutical companies with in-house animal facilities Biotechnology firms developing novel therapeutics
🧬 Basic Life Science Research Institutions
~$50M domestically (AI est.)
Research using genome-edited animals and disease model mice is intensifying in universities and research institutions, emphasizing hygiene management to ensure research data reliability.
Academic research centers Government-funded biological research institutes University animal care and use committees
🧪 Contract Research Organizations (CROs)
~$1B globally (AI est.)
As pharmaceutical development outsourcing increases, CROs require efficient and reliable animal pathogen detection technologies to ensure the quality of their contracted studies.
Global CROs offering preclinical services Specialized toxicology testing laboratories Bioanalytical service providers
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects a highly specific and sensitive method for detecting mouse pinworm genomic DNA, featuring a simplified alcohol precipitation sample preparation and a PCR system utilizing LNA-containing primers and probes. Its novelty and inventiveness were recognized over seven prior art documents, indicating a robust and difficult-to-circumvent claim scope.

Competitive White Space

This patent focuses on mouse pinworm detection. White space exists in developing similar high-sensitivity LNA-based PCR assays for other animal pathogens or human parasitic infections, or integrating this detection method into fully automated, high-throughput screening platforms.

Economic Impact
~$150K/year estimated economic impact per facility (est.).
estimated ROI · USD · AI analysis
ROI Calculation Logic

Assuming 10,000 samples are tested annually at a large animal facility, conventional methods cost an average of ~$13.50/sample (AI est.) (including labor and reagents). This technology could reduce costs by ~$3.50/sample (AI est.) due to faster testing and optimized reagents. This results in ~$100K/year (AI est.) in direct savings. Including reduced research interruption and improved data reliability, the total economic impact could reach ~$150K/year (AI est.).

Speed to Market
6× faster than in-house development
This technology features an established PCR detection protocol targeting specific DNA regions, with LNA-containing primers and probes already designed. This allows licensees to significantly shorten the basic technical verification phase and quickly begin system integration and validation. High compatibility with existing PCR equipment and standard laboratory facilities is also a key factor enabling rapid market entry.
Competitive Positioning

X: Detection Efficiency & Throughput
Y: Detection Accuracy & Reliability

Business Models & Applications
🧪 Reagent Kit Supply Model
Develop and sell high-sensitivity mouse pinworm detection kits based on this technology to research institutions, pharmaceutical companies, and CROs. This model offers recurring revenue from consumables.
🔬 Contract Testing Service Model
Offer contract testing services for pinworm screening by accepting fecal samples from animal research facilities and utilizing this technology. This model leverages specialization and high accuracy.
🖥️ Instrument & System Integration Model
Integrate this technology with automated nucleic acid extraction devices and real-time PCR systems to offer a total solution, enhancing value proposition.
Adjacent Application Opportunities
🐶 ペット・動物医療
Pet Parasite Diagnostic Solutions
This technology could be adapted for detecting gastrointestinal parasites in other companion animals (e.g., dogs, cats) by redesigning specific primers and probes. This offers potential for rapid diagnostics in veterinary clinics, improving pet health management for a market segment valued at over ~$10B globally (AI est.).
🌿 食品衛生・環境検査
Food & Environmental Contaminant DNA Detection
The high-sensitivity DNA detection capability could be repurposed for identifying fecal contamination from specific animals or environmental pathogens in food processing plants. This could enhance food safety management and strengthen HACCP systems, potentially reducing contamination incidents by 20-30%.
🌾 畜産・農業
Livestock Parasitic Disease Early Diagnostics
This technology could be applied to early and highly sensitive detection of parasitic infections in livestock (e.g., swine, poultry). This has the potential to prevent disease outbreaks, improve livestock product quality, and maintain productivity, impacting a global market worth ~$5B (AI est.).
Integration Roadmap — Estimated 12-Month Deployment
Technical Evaluation & Protocol Optimization
Duration: 3 months
Verify the technology's principles and conduct detailed optimization of fecal sample preparation and PCR protocols to align with the licensee's existing equipment.
System Development & Validation
Duration: 6 months
Develop reagent kits or build a contract testing system based on the optimized protocols. Conduct in-house pilot validation studies to evaluate performance.
Market Introduction & Operation
Duration: 3 months
Establish final product commercialization or service delivery infrastructure and initiate market rollout. Aim for long-term success through continuous operational evaluation and improvement.
Technical Feasibility
This technology leverages widely available real-time PCR instruments and common reagents (e.g., alcohol, PCR reagents) found in molecular biology laboratories, eliminating the need for new major capital investment. The LNA-containing primers and probes described in the patent claims have established synthesis techniques and can be sourced from existing reagent supply chains. Furthermore, the alcohol precipitation method for fecal sample preparation requires no specialized skills, minimizing training burden for existing lab personnel and ensuring smooth technical implementation.
Success Scenario
Implementing this technology could reduce mouse pinworm screening time by ~66% (1/3 of current time) in a licensee's research facility. This could significantly increase the number of samples a single researcher can process, potentially leading to ~$100K/year (AI est.) in labor cost savings. Additionally, high-sensitivity detection could reduce false negative risks, potentially decreasing research interruptions due to infection by 20% annually, thereby substantially improving overall R&D efficiency and reliability.
Patent Record
APPLICATION NO.
特願2020-118717
REGISTRATION NO.
7525147
FILING DATE
2020/07/09
GRANT DATE
2024/07/22
EXPIRATION DATE
2040/07/09
PATENT HOLDER
国立大学法人山口大学
Examination History
2023年06月06日
出願審査請求書
2024年05月07日
拒絶理由通知書
2024年06月04日
意見書
2024年06月04日
手続補正書（自発・内容）
2024年07月08日
特許査定